دورية أكاديمية
93P Real-world analysis of first-line maintenance (1LM) immunotherapy (IO) ± pemetrexed for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic
| العنوان: | 93P Real-world analysis of first-line maintenance (1LM) immunotherapy (IO) ± pemetrexed for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic |
|---|---|
| المؤلفون: | Minchom, A.R., Gilding, N., Tan, V., Christoforou, K., Rule, J., Aziez, A., Gomes, F., Januszewski, A. |
| المصدر: | ESMO Open ; volume 9, page 102672 ; ISSN 2059-7029 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2024 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Cancer Research, Oncology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.esmoop.2024.102672 |
| الإتاحة: | https://doi.org/10.1016/j.esmoop.2024.102672Test https://api.elsevier.com/content/article/PII:S205970292400440X?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S205970292400440X?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: | edsbas.FEE5A92B |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.esmoop.2024.102672 |
|---|